{
    "id": "correct_leader_00138_3",
    "rank": 20,
    "data": {
        "url": "https://www.globalcommissionondrugs.org/wacd",
        "read_more_link": "",
        "language": "en",
        "title": "The Global Commission on Drug Policy – West Africa Commission on Drugs",
        "top_image": "https://s0.wp.com/i/blank.jpg",
        "meta_img": "https://s0.wp.com/i/blank.jpg",
        "images": [
            "https://www.globalcommissionondrugs.org/wp-content/uploads/2018/09/GCODP_logo_F_white.png",
            "https://www.globalcommissionondrugs.org/wp-content/uploads/2018/09/GCODP_logo_F_white.png",
            "https://www.globalcommissionondrugs.org/wp-content/uploads/2017/02/Kofi-Annan-Fdtn-logo-1-300x114.jpg",
            "https://www.globalcommissionondrugs.org/wp-content/uploads/2017/03/WACD-commissioners.jpg",
            "https://www.globalcommissionondrugs.org/wp-content/uploads/2017/02/Logos-funders.png",
            "https://www.globalcommissionondrugs.org/wp-content/uploads/2017/02/OB.gif",
            "https://www.globalcommissionondrugs.org/wp-content/uploads/2021/09/Michel_Sidibe.jpg",
            "https://www.globalcommissionondrugs.org/wp-content/uploads/2017/02/Pires.gif",
            "https://www.globalcommissionondrugs.org/wp-content/uploads/2017/02/Ba.gif",
            "https://www.globalcommissionondrugs.org/wp-content/uploads/2017/02/Thompson.gif",
            "https://www.globalcommissionondrugs.org/wp-content/uploads/2017/02/Diallo.gif",
            "https://www.globalcommissionondrugs.org/wp-content/uploads/2017/02/Hesse.gif",
            "https://www.globalcommissionondrugs.org/wp-content/uploads/2017/02/Kodjo.gif",
            "https://www.globalcommissionondrugs.org/wp-content/uploads/2017/02/Kafondo.gif",
            "https://www.globalcommissionondrugs.org/wp-content/uploads/2017/02/Ogunrumbi.gif",
            "https://www.globalcommissionondrugs.org/wp-content/uploads/2017/02/Mahmood.gif",
            "https://www.globalcommissionondrugs.org/wp-content/uploads/2017/02/Oumou.gif",
            "https://www.globalcommissionondrugs.org/wp-content/uploads/2017/04/GCDP-rect-logo-for-web.png"
        ],
        "movies": [],
        "keywords": [],
        "meta_keywords": [
            ""
        ],
        "tags": null,
        "authors": [],
        "publish_date": "2017-02-21T04:47:28+00:00",
        "summary": "",
        "meta_description": "The West Africa Commission on Drugs Convened by Kofi Annan, the West Africa Commission (WACD) on Drugs comprises a group of distinguished West Africans from the worlds of politics, civil society, h…",
        "meta_lang": "en",
        "meta_favicon": "https://www.globalcommissionondrugs.org/wp-content/uploads/2018/08/GCDP_LOGOS_RED-MAP-ONLY-e1534620858124.png",
        "meta_site_name": "The Global Commission on Drug Policy",
        "canonical_link": "https://www.globalcommissionondrugs.org/wacd",
        "text": "Olusegun Obasanjo served as President of the Federal Republic of Nigeria from 1999 until 2007. Upon leaving office, he oversaw the first civilian handover of power in Nigeria from one democratically-elected leader to another. President Obasanjo’s administration tackled corruption as a major priority, establishing dedicated bodies and strengthening existing ones.\n\nOn a regional level, President Obasanjo has played a pivotal role in the regeneration and repositioning of the African Union with the African Peer Review Mechanism (APRM) and the New Partnership for Africa’s Development (NEPAD). He has consistently supported the deepening and widening of regional cooperation through the Economic Community of West African States (ECOWAS) and the Co-prosperity Alliance Zone.\n\nHe has at different times served as Chairman of the Group of 77, Chairman of the Commonwealth Heads of Government Meeting, Chairman of the African Heads of State and Government Implementation Committee on NEPAD, and today serves on the African Progress Panel to monitor and promote Africa‘s development. He was also involved in international mediation efforts in Namibia, Angola, South Africa, Mozambique and Burundi. In 2008, United Nations Secretary-General Ban Ki-moon appointed President Obasanjo as his Special Envoy on the Great Lakes.\n\nA long-standing champion of a people-centered approach to health and development and a strong advocate for social justice, Dr. Michel Hamala Sidibé was the second Executive Director of UNAIDS, serving from January 2009 until May 2019. He held the rank of Under-Secretary-General of the United Nations. His passion for advancing global health and justice began in his native Mali, where he took up the cause of the health and well-being of the nomadic Tuareg people, ultimately leading to his appointment as Mali's first country director for Terre des Hommes. In 1987, he joined the United Nations Children's Fund (UNICEF) in the Democratic Republic of Congo. During a 14-year career at UNICEF, Michel supervised technical assistance programs to 10 French-speaking countries in the formulation of their national programs. He then served as a Representative in Swaziland, Burundi, and Uganda.\n\nIn 2001, Dr. Sidibé joined UNAIDS as Country and Regional Support Director. He organized a reform to transform \"UNAIDS into a more focused, effective and efficient joint program capable of delivering results at the country level.\" In 2007, he was appointed Deputy Executive Director of Programs at UNAIDS and Assistant Secretary-General of the United Nations. In 2008, he was appointed Executive Director of UNAIDS in Geneva. Under his leadership of UNAIDS, more and more countries adopted a Fast-Track approach through which the achievement of a set of measurable targets by 2020 will set the world on course to end the AIDS epidemic as a public health threat by 2030 within the framework of the Sustainable Development Goals.\n\nIn May 2019, he was appointed Minister of Health and Social Affairs in Mali, where he developed the Mali Action Plan, modeled on the World Health Organization's framework. In 2020, he led the country's XOF 55 billion COVID-19 Response Plan and formed the National Agency for Reproductive Health to revolutionize maternal and child health in Mali. In July 2019, he was appointed by the African Union to lead the global advocacy to create the African Medicines Agency (AMA).\n\nDr. Sidibé has received honorary doctorates from universities in the United States, including Tuskegee University in Alabama, Clark University in Massachusetts, the University of British Columbia in Canada, and the University of KwaZulu-Natal. He is an Honorary Professor at the University of Stellenbosch, South Africa Dr. Sidibé is a Knight of the National Order of the Legion of Honor of France, Officer of the National Order of Mali, Officer of the National Order of Benin, and Chancellor of the National Order of Chad. He has been distinguished by the order of Saint Charles of Monaco. He is Commander of the Central African Order of Merit, Commander of the Order of the Lion of Senegal. He has been honored by the Excellency Order of the Pearl of Africa of Uganda.\n\nPedro Pires studied at the University of Lisbon together with other later leaders of liberation movements for the independence of the Portuguese colonies. With the start of fighting in Angola in 1961, he left Portugal to join Amilcar Cabral in Guinea-Bissau. Until the Carnation Revolution, he fought for independence and was then spokesman of the negotiations with Portugal. Pedro Pires served as the first Prime Minister after the independence of Cape Verde from 1975 – 1991 and as President from 2001 – 2011.\n\nDuring three successive mandates as Prime Minister his government achieved substantial gains in health, education, training and literacy, which translate into a significant improvement in the conditions of life of the population and in the protection of the environment. Cape Verde now ranks at seventh place for Sub-Sahara African countries on the Human Development Index.\n\nAt the international level, the Cape Verdean government led by Mr. Pires played an important role in the negotiation processes that led to the independence of Namibia and to the withdrawal of Cuban and South-African military forces from Angola. In 2011 he was awarded with the Mo Ibrahim Prize for Achievement in African Leadership. Currently, Mr. Pires is the President of Amilcar Cabral Foundation.\n\nEdem Kodjo is a diplomat, politician, lecturer, economist and writer. He has worked at senior levels in his home country Togo, at the West African sub-regional level as well as at the continental level. Edem Kodjo held the position of Prime Minister of Togo from 1994 to 1996, and again from 2004 to 2006. He also served as Finance Minister and Foreign Minister. He was the Secretary General of the Organisation of African Unity from 1978-1983.\n\nFor almost 10 years he was Associate Professor of Development Economics and African Studies at the Sorbonne University in Paris. He is a known writer and has authored a number of books and articles. In March 2011 Edem Kodjo was made ECOWAS Ambassador for life at the Heads of State Summit in Abuja. In May of the same year he founded the Panafrican Forum for Peace and Development, PAX AFRICANA whose main objective is to work at reducing conflict and to promote accelerated development on the continent. Edem Kodjo retired from active politics in 2009.\n\nChristine Kafando is the founder of Association Espoir pour Demain in Burkina Faso. She has held various positions, including President of the Board of Directors REGIPIV (Network for a greater involvement of people living with HIV) since 2004, founder and member of the Association REVS + (1996), member of the National Council Office of the Fight against AIDS and Sexually Transmitted Infections since 2001.\n\nShe was a consultant in the Psychosocial Medical Department at the Hospital Souro Sanou, Bobo Dioulasso from 1997 to 2003. She has also worked on representing people living with HIV at the international level. She served as the Second Vice Chair of the Country Coordinating Mechanisms/Global Fund since 2004, was a member of the Scientific Sector 6 of the ANRS (National Agency for AIDS Research) (France) from 2006 to 2010, and was a member of the Technical Advisory Committee of STF (Secure The Future), Bristol-Myers Squibb from 2005 to 2010."
    }
}